Growth factors cost up to $1M/gram and account for 95%+ of media cost

Cultivated meat companies trying to produce serum-free cell culture media face a brutal cost bottleneck: recombinant growth factors like FGF-2 and TGF-beta1 account for more than 95% of the total media cost. At commercial research-grade prices, FGF-2 costs roughly $50,000/gram and TGF-beta can reach $1,000,000/gram. So what? Culture media constitutes over 95% of total cultivated meat production cost, meaning these tiny protein inputs alone make the final product 10-100x more expensive than conventional meat per kilogram. So what? Startups cannot achieve price parity with conventional beef ($5-10/lb retail) when a single bioreactor run's media bill runs into tens of thousands of dollars. So what? This blocks any path to mass-market adoption, confining cultivated meat to novelty restaurants and press stunts rather than grocery shelves. Why does this persist? These growth factors were originally developed for pharmaceutical and biomedical research at milligram scale, not food production at metric-ton scale. The entire supply chain — from expression systems (CHO cells, E. coli) to purification and QC — is built for pharma economics where $50,000/gram is acceptable because patients need micrograms, not kilograms. Rebuilding this supply chain for food-grade, bulk-scale production requires capital investment that the cultivated meat industry, having raised only $65M in 2025 (down from $989M in 2021), cannot currently afford.